Nucleolin Overexpression Predicts Patient Prognosis While Providing a Framework for Targeted Therapeutic Intervention in Lung Cancer

Notwithstanding the advances in the treatment of lung cancer with immune checkpoint inhibitors, the high percentage of non-responders supports the development of novel anticancer treatments. Herein, the expression of the onco-target nucleolin in patient-derived pulmonary carcinomas was characterized...

Full description

Bibliographic Details
Main Author: Fernandes, Ângela Valério (author)
Other Authors: Fonseca, Nuno A. (author), Gonçalves, Nélio (author), Cruz, Ana F. (author), Pereira, Marta I. (author), Gregório, Ana C. (author), Moura, Vera (author), Ladeirinha, Ana F. (author), Alarcão, Ana (author), Gonçalves, Joana (author), Abrunhosa, Antero (author), Melo, Joana B. (author), Carvalho, Lina (author), Simões, Sérgio (author), Moreira, João N. (author)
Format: article
Language:eng
Published: 2022
Subjects:
lung cancer
nucleolin expression
targeted intracellular drug delivery
tumor microenvironment
Online Access:http://hdl.handle.net/10316/103212
Country:Portugal
Oai:oai:estudogeral.sib.uc.pt:10316/103212

Internet

http://hdl.handle.net/10316/103212

Similar Items